Marie Bosslett, Assistant Editor

In case you missed it, this week we had news about the phase 2/3 research on VDPHL01, new data on the DecisionDx-Melanoma GEP test, roflumilast's sNDA for pediatric plaque psoriasis, and more.

Mondana Ghias, MD, FAAD, discusses Tono Health's role in improving access to skin care for patients of color, addressing systemic barriers and enhancing diagnostic accuracy.

New long-term findings reveal guselkumab (TREMFYA) as the only IL-23 inhibitor effectively preventing joint damage in active psoriatic arthritis.

Maui Derm NP+PA Fall 2025 conference showcases cutting-edge insights in dermatology, featuring expert discussions on skin cancer, atopic dermatitis, and rare dermatoses.

Nada Elbuluk, MD, MSc, and Nkem Ugonabo, MD, MPH, discuss safe aesthetic procedures for skin of color, emphasizing tailored techniques and the importance of understanding unique skin biology.

Clinicians can enhance aesthetic outcomes by proactively managing GLP-1 patients' expectations, addressing facial changes early, and integrating holistic treatment strategies.

Discover how BOTOX Cosmetic Day highlights natural results and patient satisfaction, backed by new research from ASDS on diverse populations and effective treatment strategies.

New findings showcase DecisionDx-Melanoma's effectiveness in predicting sentinel lymph node positivity and enhancing recurrence risk assessment in melanoma patients.

This review of the latest dermatologic studies highlights new research on acne, including post-treatment recurrence, the use of AI, severity in cystic fibrosis patients, and more.

A recent survey reveals patients prioritize board-certified dermatologists and increasingly favor teledermatology for faster, accessible care.

Veradermics initiates a groundbreaking trial for VDPHL01, an oral minoxidil treatment, addressing female pattern hair loss with innovative solutions.

GLP-1 medications are reshaping dermatology, driving increased patient demand for treatments addressing facial volume loss and jowling concerns, according to Joely Kaufman, MD.

AEON Biopharma showcases promising biosimilar data for ABP-450, indicating strong similarity to BOTOX, paving the way for FDA approval.

Discover how viral skin care trends on social media mislead users, compromising skin health, and learn evidence-based strategies for effective care from Nerissa Prieto, MD.

A Prescription Drug User Fee Act target action date is set for June 29, 2026.

Denifanstat emerges as a groundbreaking oral therapy for acne, targeting sebum production and inflammation, promising safer, effective treatment options.

Researchers are developing an innovative mRNA vaccine targeting Merkel cell carcinoma, enhancing T cell immunity and offering new hope for effective treatment.

Arcutis advances pediatric atopic dermatitis treatment with roflumilast cream, completing enrollment in key INTEGUMENT-INFANT trial.

Explore the latest advancements and expert insights from the SDPA Fall 2025 Meeting held in San Antonio, Texas.

Karan Lal, DO, explores the transformative role of GLP-1 therapies in dermatology, highlighting their potential in treating inflammatory skin diseases and enhancing aesthetic care.

Shannon Trotter, DO, and Renata Block, DMSc, MMS, PA-C, discuss social media's impact on dermatology, highlighting trends, misinformation, and the need for clinician engagement.

Joseph Gatti, DMSc, MPAS, MBA, PA-C, discusses the impact of social media and AI on dermatology, urging professionals to adapt and educate in a rapidly evolving landscape.

Experts discuss effective strategies for managing facial hyperpigmentation, emphasizing personalized treatment plans and the importance of sun protection.

Heather Goff, MD, MPH, discusses her role as SDPA Medical Director and the vital collaboration between dermatology PAs and physicians at the 2025 fall conference.

Discover how the SDPA Diplomate Fellowship has evolved with innovative learning tools, enhancing education for dermatology PAs at the Fall 2025 conference.

Catch up on coverage from the fourth day of the 2025 SDPA Fall Conference held in San Antonio, Texas.

Heather Goff, MD, MPH, shares vital insights on lifestyle, ethics, and cutaneous lymphomas at SDPA Fall 2025, highlighting the future of dermatology.

Renata Block, DMSc, MMS, PA-C, explores how AI could enhance dermatology, improving skin cancer diagnosis while emphasizing the vital role of human clinicians in patient care.

Joseph Gatti, DMSc, MPAS, MBA, highlights the importance of collaboration between PAs and dermatologists, emphasizing mutual respect and the role of PAs in enhancing patient care.

Andrew Baker, MBA, MPAS, PA-C, discusses leadership and inclusivity in dermatology at the SDPA Fall Conference, emphasizing collaboration and member engagement for future growth.